Reactive Arthropathies
Definition And Overview
- Sterile inflammatory arthritis occurring simultaneously or following distant extra-articular infection.
- Categorized under seronegative spondyloarthropathies.
- Major subtypes include classical reactive arthritis (genitourinary or gastrointestinal triggers), post-streptococcal reactive arthritis (PSReA), and post-infectious viral arthritis.
Epidemiology And Genetics
Demographics
- Peak incidence occurs in children aged 8-12 years.
- Equal sex ratio initially, shifting to male predominance in older adolescents due to sexually transmitted infections.
- Prevalence depends on community exposure to arthritogenic bacteria and genetic susceptibility.
Genetic Associations
- Human Leukocyte Antigen B27 (HLA-B27) antigen present in 75-85% cases.
- HLA-B27 positivity correlates strongly with axial disease severity, extra-articular manifestations, and chronicity.
- Tumor necrosis factor (TNF) c1 allele and Transporter Associated with Antigen Processing (TAP2) polymorphism implicated in pathogenesis.
Pathogenesis
Mechanism Of Injury
- Incomplete elimination of bacteria or bacterial products (DNA/antigens) drives chronic inflammation.
- Bacterial mucosal invasion initiates inflammatory cascade.
- Release of proinflammatory cytokines, predominantly Interleukin-23 (IL-23) and Interleukin-17 (IL-17).
- Bacterial antigenic peptide presentation to CD4+ or CD8+ T lymphocytes triggers cross-reactive autoimmune responses.
- Molecular mimicry between pathogen antigens and host joint tissues.
- Chlamydia trachomatis uniquely persists in monocytes, traveling directly to synovium to incite local inflammatory response.
Etiological Agents
Organisms Triggering Classical Reactive Arthritis
| Infection Source | Common Pathogens | Less Common Pathogens |
|---|---|---|
| Gastrointestinal | Salmonella enteritidis, Shigella flexneri, Yersinia enterocolitica, Campylobacter jejuni | Clostridium difficile, Giardia lamblia, Cryptosporidium, Entamoeba histolytica |
| Genitourinary | Chlamydia trachomatis | Neisseria gonorrhoeae, Ureaplasma urealyticum, Mycoplasma genitalium |
| Respiratory | Chlamydia pneumoniae, Mycoplasma pneumoniae | Streptococcus pyogenes |
Clinical Manifestations
Disease Chronology
- Latent period averages 3-4 weeks post-infection, ranging from 3 days to 6 weeks.
- Arthritis symptoms may overlap with active initial infection (e.g., ongoing bloody dysentery).
Articular Features
- Asymmetric oligoarthritis or monoarthritis.
- Marked predilection for lower extremity weight-bearing joints (knees, ankles).
- Non-migratory, additive progression pattern.
- Dactylitis (diffuse sausage-like digit swelling) observed in up to 40%.
- Enthesitis highly prevalent (up to 90%), predominantly affecting Achilles tendon or plantar fascia insertion.
- Sacroiliitis occurs in 20% cases, primarily in HLA-B27 positive individuals.
Extra-Articular Features
| Organ System | Specific Manifestations |
|---|---|
| Mucocutaneous | Keratoderma blennorrhagica (hyperkeratotic scaly plaques on soles/palms resembling pustular psoriasis), erythema nodosum, painless oral ulcers, nail pitting/onycholysis |
| Genitourinary | Urethritis, cervicitis, vaginitis, circinate balanitis (painless shallow ulcers on glans penis affecting 20-30% males) |
| Ocular | Acute symptomatic anterior uveitis, conjunctivitis, episcleritis |
| Constitutional | High fever, severe malaise, fatigue, significant weight loss |
| Cardiac | Aortic valve involvement, myocarditis, pericarditis (rare, occasionally seen with Salmonella) |
Diagnostic Evaluation
Berlin Criteria (1995)
- Asymmetric peripheral arthritis (predominantly lower limb).
- Evidence of preceding infection (clinical history of diarrhea/urethritis within 4 weeks or laboratory confirmation).
- Strict exclusion of other defined spondyloarthropathies.
Laboratory Investigations
- Erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and platelets markedly elevated reflecting systemic inflammation.
- Complete blood count reveals neutrophilic leukocytosis; severe cases manifest anemia of chronic disease.
- Autoantibodies (Antinuclear Antibody, Rheumatoid Factor) consistently test negative.
- HLA-B27 genetic testing positive in up to 80-85%.
Microbiological Workup
- Stool culture essential for identifying enteric pathogens.
- Urine nucleic acid amplification test (NAAT) or urethral swab for Chlamydia/Gonococcus DNA detection via polymerase chain reaction (PCR).
- Specific serological markers (hemagglutination) for Salmonella and Yersinia.
- Synovial fluid analysis: Turbid fluid, extremely high leukocyte counts (often >50,000/microL with neutrophil predominance), but sterile routine bacterial cultures. Synovial fluid PCR may detect offending bacterial DNA.
Radiologic Evaluation
- Plain radiographs demonstrate non-specific joint effusion, soft tissue swelling, or widened joint space.
- Ultrasonography confirms joint effusion, tenosynovitis, and localized enthesitis.
- Chronic stages reveal spur formation at plantar fascia insertion, erosions, or sacroiliac joint changes identical to ankylosing spondylitis.
Post-Streptococcal Reactive Arthritis (PSReA)
Characteristics
- Non-purulent complication following Group A Beta-Hemolytic Streptococcus (GABHS) upper respiratory tract infection.
- Specifically fails to fulfill revised Jones criteria for Acute Rheumatic Fever (ARF) diagnosis.
- Bimodal age distribution: Early peak at 8-14 years, late peak at 21-37 years.
- Genetic vulnerability linked to inheritance of HLA-DRB1*01 allele.
Differentiation From Acute Rheumatic Fever
| Clinical Parameter | Post-Streptococcal Reactive Arthritis (PSReA) | Acute Rheumatic Fever (ARF) |
|---|---|---|
| Latent Period | Short (<10 days) | Long (2-3 weeks) |
| Arthritis Pattern | Additive, persistent, non-migratory | Fleeting, highly migratory |
| Joint Distribution | Large joints, significant axial skeleton/small joint involvement | Exclusively large joints (knees, ankles, wrists) |
| Response To Salicylates | Poor to moderate, incomplete resolution | Dramatic, rapid symptom resolution |
| Carditis Risk | Rare (~8%), late subclinical presentation | Common, potentially severe |
| Duration Of Arthritis | Prolonged (>2 months) | Brief (1-2 weeks untreated) |
Specific Management Of PSReA
- Joint symptoms exhibit poor response to standard Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).
- Systemic corticosteroid therapy provides favorable, rapid relief.
- Secondary antibiotic prophylaxis recommended for 1-2 years following primary episode; extended prophylaxis indicated if valvular heart disease develops prospectively.
General Management Principles
Pharmacotherapy
- NSAIDs represent first-line symptomatic therapy for pain and inflammation control.
- Intra-articular corticosteroid injections (triamcinolone hexacetonide) administered for refractory mono/oligoarthritis following definitive exclusion of septic arthritis.
- Short course low-dose systemic corticosteroids (5-10 mg daily for 1-2 weeks) hasten recovery in severe, incapacitating acute episodes.
- Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) (methotrexate, sulfasalazine) indicated for chronic persistent arthritis, severe keratoderma blennorrhagica, or refractory uveitis.
- Biologic agents (TNF inhibitors: infliximab, adalimumab) reserved for severe axial disease, treatment-resistant enthesitis, or complete DMARD failure.
- Systemic antimicrobials indicated exclusively for documented, ongoing antecedent infections (e.g., active Chlamydial urethritis). Routine antibiotic administration does not alter long-term joint disease trajectory.
Supportive Care
- Early mobilization, active physical therapy, and customized orthotics (heel cups) preserve joint function and prevent localized muscle atrophy.
Prognosis And Complications
- Usually follows self-limiting monophasic course, resolving completely within 6 weeks in pediatric populations.
- Chronic or recurrent arthritis/enthesitis develops in 15-30% of patients.
- Direct progression to Enthesitis-Related Arthritis (ERA) or fully expressed Juvenile Idiopathic Arthritis (JIA) documented in subset of cases.
- Chronicity risk factors include HLA-B27 genetic positivity and presence of extra-articular manifestations (triad of arthritis, urethritis, conjunctivitis).
- Uveitis related to reactive arthritis generally maintains benign course without permanent ocular sequelae.